Literature DB >> 1420598

Glycosylation of the interleukin-1 receptor type I is required for optimal binding of interleukin-1.

J Mancilla1, T Ikejima, C A Dinarello.   

Abstract

The two types of cell surface receptors for interleukin-1 (IL-1) are glycoproteins that contain N-glycosidic chains on their extracellular portions. To determine the role of glycosylation of the IL-1 receptor type I (IL-1RtI) in the binding and function of IL-1, we used four plant lectins and glycosidase treatment on two different T-cell lines (EL4-6.1 and D10S) and expressing high number of binding sites for IL-1. The lectins wheat germ agglutinin, phytohemagglutinin, and concanavalin A inhibited in a dose-response manner the IL-1-induced proliferation of D10S cells. Binding of IL-1 was blocked and radioactive IL-1 was displaced from these cells by these lectins. Specific sugars (GlcNAc, NeuAc, Gal-GlcNAc-Man, Man, or alpha-MeMan) did not themselves affect IL-1 binding but reversed the blocking effects of the lectins. The two cell lines differed in their responses to the lectin-mediated inhibition of IL-1 binding. Digestion by N-glycosidase significantly decreased the capacity of cells to bind IL-1, and reduced by approximately 20,000 D the M(r) of the IL-1RtI. Neuraminidase and O-glycanase treatment did not alter the binding of IL-1 to D10S or EL4-6.1 cells. This study demonstrates that glycosylation of the extracellular domain of the IL-1RtI is due to N-linked carbohydrates, that the degree of glycosylation can vary in cells of different lineage, and that this N-linked glycosylation appears to be essential for optimal binding and activity of IL-1 to its type I receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420598

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  4 in total

1.  In vitro biological activities of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with N-acetylneuraminic acid.

Authors:  K Moriya; T Chiba; S Nabeshima; H Hayashi; K Onozaki
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

2.  Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with D-galactose monosaccharide: biological activities in vivo.

Authors:  S Nabeshima; T Chiba; Y Takei; A Ono; K Moriya; K Onozaki
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

3.  Base-modified UDP-sugars reduce cell surface levels of P-selectin glycoprotein 1 (PSGL-1) on IL-1β-stimulated human monocytes.

Authors:  Varsha Kanabar; Lauren Tedaldi; Jingqian Jiang; Xiaodan Nie; Irina Panina; Karine Descroix; Francis Man; Simon C Pitchford; Clive P Page; Gerd K Wagner
Journal:  Glycobiology       Date:  2016-05-27       Impact factor: 4.313

4.  Penta-o-galloyl-beta-d-Glucose (PGG) inhibits inflammation in human rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis model.

Authors:  Sadiq Umar; Anil K Singh; Mukesh Chourasia; Stephanie M Rasmussen; Jeffrey H Ruth; Salahuddin Ahmed
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.